Research roundup

Debbie Rigby presents the latest in research news Non-major bleeding with apixaban versus warfarin in patients with atrial fibrillation In ARISTOTLE study, non-major bleeding was common and substantially less frequent with apixaban than with warfarin. Non-major bleeding was three times more common than major bleeding (12.1% vs 3.8%). Non-major bleeding was less frequent with apixaban